Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Moberg Pharma

10.28 SEK

-0.96 %

Less than 1K followers

MOB

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Moberg Pharma

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue3.91.09.83.93.64.02.113.5
EBITDA-3.0-7.8-23.5-3.7-9.3-5.6-7.1-25.7
EBIT-3.3-308.1-324.8-4.1-9.7-6.0-7.5-27.3
EBIT-%-85.5 %-29,915.5 %-3,311.2 %-106.7 %-270.3 %-149.8 %-360.4 %-201.8 %
Profit before taxes-1.6-306.0-320.5-3.2-8.7-5.2-7.0-24.0
Net income-1.3-243.3-255.1-2.8-7.4-4.3-12.8-27.2
Login required

This content is only available for logged in users

Create account
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.